title: Can we rely on RE-LY?
authors.forename: Brian F
authors.initials: BF
authors.lastname: Gage
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D000069604:Dabigatran; D006801:Humans; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects; D020521:Stroke / Q000453:epidemiology / Q000517:prevention & control; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran